DK0816413T3 - Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel - Google Patents

Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel

Info

Publication number
DK0816413T3
DK0816413T3 DK97202586T DK97202586T DK0816413T3 DK 0816413 T3 DK0816413 T3 DK 0816413T3 DK 97202586 T DK97202586 T DK 97202586T DK 97202586 T DK97202586 T DK 97202586T DK 0816413 T3 DK0816413 T3 DK 0816413T3
Authority
DK
Denmark
Prior art keywords
hydrophilic
pharmaceutical preparation
preparation containing
containing pure
lipophilic drug
Prior art date
Application number
DK97202586T
Other languages
Danish (da)
English (en)
Inventor
Walter Prikoszovich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016840A external-priority patent/GB9016840D0/en
Priority claimed from GB909016882A external-priority patent/GB9016882D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0816413T3 publication Critical patent/DK0816413T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88Post-polymerisation treatment
    • C08G63/90Purification; Drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08Lactones or lactides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97202586T 1990-08-01 1991-07-29 Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel DK0816413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016840A GB9016840D0 (en) 1990-08-01 1990-08-01 Improvements in or relating to organic compounds
GB909016882A GB9016882D0 (en) 1990-08-01 1990-08-01 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
DK0816413T3 true DK0816413T3 (da) 2005-08-29

Family

ID=26297417

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91112725T DK0469520T3 (da) 1990-08-01 1991-07-29 Fremgangsmåde til fremstilling af rent polylactid
DK97202586T DK0816413T3 (da) 1990-08-01 1991-07-29 Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91112725T DK0469520T3 (da) 1990-08-01 1991-07-29 Fremgangsmåde til fremstilling af rent polylactid

Country Status (27)

Country Link
EP (2) EP0816413B1 (zh)
JP (1) JP3137368B2 (zh)
KR (1) KR100255904B1 (zh)
AT (1) AT402503B (zh)
AU (1) AU650277B2 (zh)
CA (1) CA2048200C (zh)
CH (1) CH683772A5 (zh)
CY (1) CY1986A (zh)
DE (1) DE4124468B4 (zh)
DK (2) DK0469520T3 (zh)
ES (2) ES2112259T3 (zh)
FI (2) FI108040B (zh)
FR (1) FR2665453B1 (zh)
GB (1) GB2246573B (zh)
GR (1) GR3026322T3 (zh)
HK (1) HK11797A (zh)
HU (1) HUT59837A (zh)
IE (1) IE66185B1 (zh)
IL (1) IL99007A (zh)
IT (1) IT1252944B (zh)
LU (1) LU87985A1 (zh)
MY (1) MY108621A (zh)
NO (1) NO912960D0 (zh)
NZ (1) NZ239184A (zh)
PH (1) PH31047A (zh)
PT (1) PT98491B (zh)
TW (2) TW282477B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5225521A (en) * 1991-12-31 1993-07-06 E. I. Du Pont De Nemours And Company Star-shaped hydroxyacid polymers
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
JPH06116381A (ja) * 1992-10-09 1994-04-26 Mitsui Toatsu Chem Inc ポリヒドロキシカルボン酸の精製方法
DE4412317A1 (de) * 1993-04-21 1994-10-27 Basf Ag Polylactid mit verbreiterter Molmassenverteilung
US5359026A (en) * 1993-07-30 1994-10-25 Cargill, Incorporated Poly(lactide) copolymer and process for manufacture thereof
US5496923A (en) * 1993-09-20 1996-03-05 Mitsui Toatsu Chemicals, Inc. Purification process of aliphatic polyester
ATE288270T1 (de) * 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
JPH08510761A (ja) * 1994-03-07 1996-11-12 ザ・ダウ・ケミカル・カンパニー 生物活性及び/又はターゲテッドデンドリマー複合体
AU5862199A (en) 1998-09-11 2000-04-03 Michael Raschke Biologically active implants
US6362308B1 (en) * 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
JP4231781B2 (ja) * 2001-07-10 2009-03-04 株式会社クレハ ポリグリコール酸及びその製造方法
MXPA04003433A (es) * 2001-10-10 2004-08-11 Pf Medicament Microesferas biodegradables de liberacion prolongada y metodo para preparar las mismas.
FR2830448B1 (fr) * 2001-10-10 2004-03-19 Pf Medicament Microspheres biodegradables a liberation prolongee et leur procede de preparation
AU2013204972B2 (en) * 2002-11-19 2016-04-21 Novartis Ag Pharmaceutical composition comprising octreotide microparticles
GB0226993D0 (en) * 2002-11-19 2002-12-24 Novartis Ag Organic compounds
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
EP1787658B1 (en) 2005-11-10 2012-03-14 CHEMI S.p.A. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
CN101193531B (zh) 2006-11-29 2010-12-01 富准精密工业(深圳)有限公司 散热装置
EP2229417B1 (en) * 2007-12-31 2014-07-30 Samyang Biopharmaceuticals Corporation Process for the preparation of highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid
EP2411440B1 (en) * 2009-03-23 2018-01-17 Micell Technologies, Inc. Improved biodegradable polymers
JP5594996B2 (ja) 2009-09-14 2014-09-24 三菱重工業株式会社 航空機の操縦システム
DE202011110978U1 (de) * 2010-06-21 2017-11-27 Lg Chem, Ltd. Polylactidharz mit ausgezeichneter Wärmebeständigkeit
EP2455414A1 (de) * 2010-11-17 2012-05-23 Evonik Röhm GmbH Verfahren zur Herstellung von hochmolekularen, resorbierbaren Polyestern, die mit dem Verfahren herstellbaren hochmolekularen resorbierbaren Polyester und deren Verwendung
EP2455415A1 (de) * 2010-11-17 2012-05-23 Evonik Röhm GmbH Verfahren zur Herstellung von niedermolekularen, resorbierbaren Polyestern, die mit dem Verfahren herstellbaren niedermolekularen resorbierbaren Polyester und deren Verwendung
CN105820332B (zh) * 2015-01-09 2018-06-29 北京化工大学 一种星形聚氨基酸和星形聚氨基酸载药纳米胶束及制备方法
EP3408305B1 (en) 2016-01-29 2024-03-06 Tolmar Inc. Purification and decolorization of polymers
WO2019046748A1 (en) * 2017-08-31 2019-03-07 Evonik Corporation ENHANCED RESORBABLE POLYMER PURIFICATION METHOD
GR1009392B (el) * 2017-09-19 2018-10-25 Φαρματεν Αβεε Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδικο φαρμακο και μεθοδος για την παρασκευη αυτου
GB2568526A (en) * 2017-11-20 2019-05-22 Rebio Tech Oy Composition
CN112940234B (zh) * 2021-01-28 2022-05-03 广东粤港澳大湾区黄埔材料研究院 一种高纯度聚乙丙交酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467970A (en) * 1975-05-02 1977-03-23 Ici Ltd Purification of polyethers
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
CA1236641A (en) * 1984-07-06 1988-05-10 Motoaki Tanaka Copolymer of lactic acid and glycolic acid and method for producing same
EP0181621B1 (en) * 1984-11-13 1991-09-04 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of polyalkylene ether
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
JPH0610252B2 (ja) * 1985-08-21 1994-02-09 和光純薬工業株式会社 重合体の製造法
DE3641692A1 (de) * 1986-12-06 1988-06-09 Boehringer Ingelheim Kg Katalysatorfreie resorbierbare homopolymere und copolymere
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JP2714454B2 (ja) * 1988-11-07 1998-02-16 三井東圧化学株式会社 生体吸収性ポリエステルの製造方法
ATE168391T1 (de) * 1990-04-13 1998-08-15 Takeda Chemical Industries Ltd Biologisch abbaubare hochmolekulare polymere, ihre herstellung und ihre verwendung

Also Published As

Publication number Publication date
IT1252944B (it) 1995-07-05
PH31047A (en) 1998-02-03
EP0816413A3 (en) 1998-11-11
ES2243966T3 (es) 2005-12-01
ATA151591A (de) 1996-10-15
DE4124468A1 (de) 1992-02-06
HUT59837A (en) 1992-07-28
CH683772A5 (de) 1994-05-13
ES2112259T3 (es) 1998-04-01
LU87985A1 (fr) 1993-02-15
GB2246573B (en) 1994-05-11
GB9116396D0 (en) 1991-09-11
AU650277B2 (en) 1994-06-16
FI108040B (fi) 2001-11-15
NZ239184A (en) 1994-09-27
EP0816413B1 (en) 2005-06-08
PT98491A (pt) 1992-06-30
AT402503B (de) 1997-06-25
DK0469520T3 (da) 1998-09-23
FI913641A (fi) 1992-02-02
TW218025B (zh) 1993-12-21
AU8143091A (en) 1992-02-27
MY108621A (en) 1996-10-31
DE4124468B4 (de) 2010-10-28
TW282477B (zh) 1996-08-01
IL99007A (en) 1994-12-29
KR100255904B1 (ko) 2000-05-01
EP0469520B1 (en) 1998-02-25
EP0816413A2 (en) 1998-01-07
HU912452D0 (en) 1991-12-30
GB2246573A (en) 1992-02-05
EP0469520A2 (en) 1992-02-05
GR3026322T3 (en) 1998-06-30
KR920003990A (ko) 1992-03-27
CA2048200A1 (en) 1992-02-02
HK11797A (en) 1997-02-14
NO912960D0 (no) 1991-07-30
FR2665453B1 (fr) 1995-01-27
CA2048200C (en) 1999-06-29
PT98491B (pt) 1997-12-31
ITRM910553A0 (it) 1991-07-23
CY1986A (en) 1997-09-05
ITRM910553A1 (it) 1993-01-23
FI111268B (fi) 2003-06-30
IE912697A1 (en) 1992-02-12
IL99007A0 (en) 1992-07-15
JPH0641279A (ja) 1994-02-15
FR2665453A1 (fr) 1992-02-07
IE66185B1 (en) 1995-12-13
FI913641A0 (fi) 1991-07-30
FI20011189A (fi) 2001-06-05
EP0469520A3 (en) 1992-10-07
JP3137368B2 (ja) 2001-02-19

Similar Documents

Publication Publication Date Title
DK0816413T3 (da) Farmaceutisk præparat indeholdende rent polylactid og et hydrofilt eller lipofilt lægemiddel
FI954767A0 (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
IT1243541B (it) Dispositivo di somministrazione in particolare di sostanza farmaceutica
DK314789D0 (da) Quinolinetheralkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
EE03110B1 (et) Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
IT8822770A0 (it) Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
EP0237073A3 (en) Il-1alpha derivatives and drugs
PT81969A (de) 11beta-phenyl-gonane deren herstellung und diese enthaltende pharmazeutische praparate
DE69015842T2 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
PH25104A (en) Acyl derivatives and pharmaceutical preparation thereof
GB2229094B (en) Pharmaceutical capsules containing ranitidine
IL88846A0 (en) Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE68903536D1 (de) Pharmazeutische granula und daraus hergestellte tabletten.
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
DK48790A (da) Steroidforbindelse og farmaceutisk praeparat indeholden en saadan forbindelse
DK559088D0 (da) Farmaceutisk praeparat indeholdende et sympathominetisk laegemiddel og piperidinoalkanol
PH24960A (en) Acyl derivatives and pharmaceutical preparation thereof
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
DK269289A (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK590987A (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid